Details about the neuroanatomical projections from ORBl to ECT

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
91833 Orbital area lateral partEctorhinal area strongbiotinylated dextran amine (BDA)
a dense plexus of labeled axons and axonal varicosities in rostral PER, especially in the fundus and the dorsal bank of the rhinal sulcus, involving dorsal area 35 and ventral area 36 (Figs. 7B, 11D). Collator note: the terminal field is extending for a small portion in the ventral corner of the PERI in this level, and is mostly in layer III, with some extension in layer V. See Fig. 7B, Swanson Atlas Levels 33-34.
Kondo H. & Witter M.P., 2014
91835 Orbital area lateral partEctorhinal area moderate/strongbiotinylated dextran amine (BDA)
[…] labeling extended farther rostrally in this case (Fig. 7A) compared with MO (Fig. 4) and ventral VO (Fig. 6) cases. Collator note: strong-moderate label in both PERI and ECT, rostralmost. Terminals are intermingled with fibers of passage, and are distributed in layers III and V. See Fig. 7A, Swanson Atlas Levels 31-32.
Kondo H. & Witter M.P., 2014
91838 Orbital area lateral partEctorhinal area very lightbiotinylated dextran amine (BDA)
Collator note: very few terminals and possible fibers of passage in the central part of the ECT. See Fig. 7C, Swanson Atlas Levels 35-36.
Kondo H. & Witter M.P., 2014
91840 Orbital area lateral partEctorhinal area lightbiotinylated dextran amine (BDA)
Collator note: few terminals in the caudalmost part of the ECT. See Fig. 7E-F, Swanson Atlas Levels 44-47.
Kondo H. & Witter M.P., 2014
91843 Orbital area lateral partEctorhinal area light/moderatebiotinylated dextran amine (BDA)
In POR, only weak labeling was present (Fig. 7F), which is distinct from that seen in VO cases. Collator note: weak-moderate labeling in the caudalmost part of the ECT, in layers II-III. See Fig. 7F, Swanson Atlas Levels 46-47.
Kondo H. & Witter M.P., 2014
91850 Orbital area lateral partEctorhinal area lightbiotinylated dextran amine (BDA)
Collator note: few terminals in layer III in the ventral corner of the rostralmost ECT. See Fig. 8A, Swanson Atlas Levels 30-31.
Kondo H. & Witter M.P., 2014
91864 Orbital area lateral partEctorhinal area moderate/strongbiotinylated dextran amine (BDA)
Collator note: weak-moderate field in the deep layers of the PERI, and moderate-strong in the dorsal part, extending into the ECT in this level. See Fig. 11F.
Kondo H. & Witter M.P., 2014
General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6.

Further details associated to record number 91838:
Position of injection: mid-rostro-caudal
Topological position of injection: is contained
Extension of injection outside: none
The injection was performed in: left hemisphere
Position of terminal field: mid-rostro-caudal
Topological position of terminal field: is contained
Extension of terminal field outside: none
The terminal field was found: ipsilateral